How Has the Self-Expanding Stents Market Evolved Historically and What is its Current Size?
The self-expanding stents market has seen considerable growth due to a variety of factors.
• The self-expanding stents market has grown strongly in recent years. It will grow from $3.31 billion in 2024 to $3.51 billion in 2025, at a CAGR of 6.0%.
This growth is due to increased awareness, a growing aging population, the expansion of stent usage beyond coronary arteries, rising disposable income, and the adoption of minimally invasive procedures.
What is the Forecasted Market Size and CAGR for the Self-Expanding Stents Market?
The self-expanding stents market is expected to maintain its strong growth trajectory in upcoming years.
• The self-expanding stents market is expected to reach $4.4 billion by 2029, growing at a CAGR of 5.8%.
This growth is attributed to the rising incidence of cardiovascular diseases, expansion of healthcare infrastructure, growth of telemedicine services, increasing peripheral arterial disease cases, and chronic diseases prevalence. Technological advancements, bioresorbable and drug-eluting stents, minimally invasive procedures, and AI integration are major trends.
What Key Factors and Trends Are Driving The Growth Self-Expanding Stents Market?
The increasing occurrence of cardiovascular conditions is anticipated to stimulate the expansion of the self-expanding stents market. Cardiovascular conditions are disorders related to the heart and blood vessels. The rise in such diseases is attributed to factors like obesity, an aging population, and genetic predispositions. Self-expanding stents play a significant role in the treatment of cardiovascular medical conditions as they offer efficient and minimally invasive treatment options for immediate and long-term patient needs. For instance, the British Heart Foundation, a renowned cardiovascular research charity based in the UK, reported in September 2024, that nearly 7.6 million people in the UK, including approximately 4 million men and 3.6 million women, suffer from heart and circulatory diseases. These conditions account for around 27% of total fatalities in the UK, representing over 170,000 deaths per year or almost 480 deaths per day, amounting to one death every three minutes. Hence, the escalating occurrence of cardiovascular conditions is fuelling the expansion of the self-expanding stents market.
What Are The Market Segments In The Self-Expanding Stents Market?
The self-expanding stents market covered in this report is segmented –
1) By Product Type: Gastrointestinal Self-Expanding Stents, Carotid Self-Expanding Stents, Endovascular Self-Expandable Stents, Other Product Types
2) By Applications: Fem-Pop Artery Stents, Iliac Artery Stents, Carotid Artery Stents, Biliary Stents, Other Applications
3) By End-Users: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Gastrointestinal Self-Expanding Stents: Esophageal Stents, Duodenal Stents, Colonic Stents
2) By Carotid Self-Expanding Stents: Balloon-Expandable Carotid Stents, Self-Expanding Carotid Stents
3) By Endovascular Self-Expandable Stents: Aortic Stents, Renal Artery Stents, Peripheral Artery Stents
4) By Other Product Types: Biliary Self-Expanding Stents, Urological Self-Expanding Stents
Pre-Book The Self-Expanding Stents Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Self-Expanding Stents Market?
Leading corporations in the self-expanding stents industry are honing in on presenting solutions like tracheal stent systems to decrease the necessity of invasive surgery and gain a competitive advantage in the marketplace. A tracheal stent system is a clinical tool utilized to fortify and preserve the openness of the trachea, often used in scenarios of tracheal tightening or breakdown. To name an example, in February 2022, Micro-Tech Endoscopy Inc., a medical technology firm from the United States, unveiled a tracheobronchial nitinol y-stent. This stent, a flexible, self-exapanding component made of a nitinol alloy, comes with a discreet delivery mechanism, a silicone layer to ward off tumor development, and movable sutures for adjustments or removal. This stent alleviates symptoms in those suffering from tracheobronchial constrictions by widening the airway and improving airflow.
Who Are the Key Players In The Self-Expanding Stents Market?
Major companies operating in the self-expanding stents market are:
• Abbott Laboratories
• Medtronic PLC
• Stryker Corporation
• Boston Scientific Corporation
• Becton
• Dickinson and Company (BD Interventional)
• Terumo Corporation
• Phenox GmbH
• Balton Sp. z o.o.
• Biotronik SE & Co. KG
• Merit Medical Systems Inc.
• Aesculap AG
• MicroVention Inc.
• Lifetech Scientific Corporation
• Cordis Corporation
• Rontis Corporation
• Veryan Medical Ltd.
• Andramed GmbH
• Medinol Ltd.
• iVascular SLU
• HEXACATH SAS
• Eucatech AG
• Endospan Ltd.
• Endo-Flex GmbH
• Endocor GmbH
What Are The Regional Insights Into The Self-Expanding Stents Market?
North America was the largest region in the self-expanding stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-expanding stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
